Vitrafy Life Sciences Limited (ASX:VFY)
Australia · Delayed Price · Currency is AUD 3.380
-0.170 (-4.79%)
Sep 15, 2026, 4:10 PM AEST
Vitrafy Life Sciences Market Cap
Vitrafy Life Sciences has a market cap or net worth of 270.51 million as of September 14, 2026. Its market cap has increased by 238.93% in one year.
Market Cap
270.51M
Enterprise Value
229.59M
Revenue
209.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.38
ChartMarket Cap Chart
Since November 26, 2024, Vitrafy Life Sciences's market cap has increased from 126.42M to 270.51M, an increase of 113.97%. That is a compound annual growth rate of 52.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 270.51M | 230.99% |
| Dec 30, 2025 | 81.73M | -24.71% |
| Dec 31, 2024 | 108.54M | -14.14% |
| Nov 26, 2024 | 126.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cuscal | 1.08B |
| FINEOS Corporation Holdings | 783.24M |
| Aura Consolidated Group | 781.01M |
| Tyro Payments | 359.83M |
| Acusensus | 203.28M |
| Wrkr Ltd | 140.73M |
| Decidr AI Industries | 107.51M |
| EML Payments | 96.50M |